PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cause, potential treatments ID'd for persistent COVID-19 lung problems

2024-09-05
(Press-News.org)

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.

By examining damaged human lungs and developing an innovative new lab model, the scientists identified faulty immune processes responsible for the ongoing lung issues that plague an increasing number of people after they’ve otherwise recovered from COVID-19. These lasting harms of COVID infection, known as “post-infection lung fibrosis,” have no good treatments. The new research, however, suggests that existing drugs such as baricitinib and anakinra can disrupt the malfunctioning immune response and finally allow damaged lungs to heal.

“Our collaboration with doctors and computer biologists at UVA and Cedars-Sinai, including Drs. Chen and Zang, led us to uncover the root cause of persistent lung inflammation and scarring after severe acute COVID-19 and possibly other respiratory infections like the flu,” said researcher Jie Sun, PhD, of UVA’s Carter Center for Immunology Research and UVA’s Division of Infectious Diseases and International Health. “Using advanced technologies like spatial transcriptomics and sophisticated microscopy, we compared lung tissues from patients and animal models we developed in the lab. We found that malfunctioning immune cells disrupt the proper healing process in the lungs after viral damage. Importantly, we also identified the molecules responsible for this issue and potential therapeutic options for patients with ongoing lung damage.”

“‘Spatial-omics’ are state-of-the-arts technologies that can measure the molecular features with spatial location information within a sample,” explained researcher Chongzhi Zang, PhD, of UVA’s Department of Genome Sciences. “This work demonstrates the power of spatial transcriptomics combined with data science approaches in unraveling the molecular etiology of long COVID.”

The researchers note that the findings could prove beneficial not just for lung scarring from COVID but for lung fibrosis stemming from other sources as well.

“This study shows that treatments used for the acute COVID-19 disease may also reduce the development of chronic sequelae, including lung scarring,” said Peter Chen, MD, the Medallion Chair in Molecular Medicine and interim chair of the Department of Medicine at Cedars-Sinai. “Our work will be foundational in developing therapies for lung fibrosis caused from viruses or other conditions.”

Understanding COVID-19 Lung Damage

The researchers – led by Sun, Chen and Zang – wanted to better understand the cellular and molecular causes of the lingering lung problems that can follow COVID infections. These problems can include ongoing lung damage and harmful inflammation that persists well after the COVID-19 virus has been cleared from the body.

The researchers began by examining severely damaged lungs from transplant patients at both UVA and Cedars-Sinai. None of the patients had a lung disease that would have required a transplant prior to contracting COVID-19, so the scientists were hopeful that the lungs would provide vital clues as to why the patients suffered such severe lung damage and persistent fibrosis. Using the insights they obtained, the scientists then developed a new mouse model to understand how normally beneficial immune responses were going awry. 

The researchers found that immune cells known as CD8+ T cells were having faulty interactions with another type of immune cell, macrophages. These interactions were causing the macrophages to drive damaging inflammation even after the initial COVID-19 infection had resolved, when the immune system would normally stand down. 

The scientists remain uncertain about the underlying trigger for the immune malfunction – the immune system may be responding to lingering remnants of the COVID-19 virus, for example, or there could be some other cause, they say.

The new research suggests that this harmful cycle of inflammation, injury and fibrosis can be broken using drugs such as baricitinib and anakinra, both of which have already been approved by the federal Food and Drug Administration to treat the harmful inflammation seen in rheumatoid arthritis and alopecia, a form of hair loss.

While more study is needed to verify the drugs’ effectiveness for this new purpose, the researchers hope their findings will eventually offer patients with persistent post-COVID lung problems much-needed treatment options.

“Tens of millions of people around the world are dealing with complications from long COVID or other post-infection syndromes,” Sun said. “We are just beginning to understand the long-term health effects caused by acute infections. There is a strong need for more basic, translational and clinical research, along with multi-disciplinary collaborations, to address these unmet needs of patients.” 

Findings Published

The scientists have published their findings in the prestigious journal Nature. The research team consisted of Harish Narasimhan, In Su Cheon, Wei Qian, Shengen Shawn Hu, Tanyalak Parimon, Chaofan Li, Nick Goplen, Yue Wu, Xiaoqin Wei, Young Min Son, Elizabeth Fink, Gislane de Almeida Santos, Jinyi Tang, Changfu Yao, Lyndsey Muehling, Glenda Canderan, Alexandra Kadl, Abigail Cannon, Samuel Young, Riley Hannan, Grace Bingham, Mohammed Arish, Arka Sen Chaudhari, Jun sub Im, Cameron L.R. Mattingly, Patcharin Pramoonjago, Alberto Marchesvsky, Jeffrey Sturek, Jacob E. Kohlmeier, Yun Michael Shim, Judith Woodfolk, Zang, Chen and Sun. Sun receives support for work unrelated to this research from Icosavax, while Woodfolk receives unrelated support from Regeneron. 

The research was supported by the National Institutes of Health, grants AI147394, AG069264, AI112844, HL170961, AI176171, AI154598, F31HL164049-01A1, F31HL170746, R01HL132287, R01HL167202, R01HL132177, R35HL150803 and T32AI007496; and the Emory Center of Excellence for Influenza Research and Response, grant 75N93019R0028.

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Pregnant women exposed to PFAS may be at risk for obesity, heart disease later in life

2024-09-05
WASHINGTON—Women with higher levels of per- and polyfluoroalkyl substances (PFAS) during pregnancy may experience long-term weight gain and heart problems later in life, according to new research published in The Journal of Clinical Endocrinology & Metabolism. PFAS are manmade chemicals found in food packaging, cookware, clothes, drinking water, personal care products and many other consumer goods. These endocrine-disrupting chemicals (EDCs) can interfere with hormones and cause health issues such as obesity, infertility and cancer. “Our study supports the idea that pregnancy may be ...

Skin fungus colonization accelerates breast cancer tumor growth

2024-09-05
Washington, D.C. — A common skin fungus, Malassezia globosa may invade deep tissues through the skin or by other means, then cause tumor growth, according to a new study. The study results were reported in mBio, an open access journal of the American Society for Microbiology. “It is important to take care of skin not only for beauty, but also for health,” said corresponding study author Qi-Ming Wang, Ph.D., a professor in the School of Life Sciences, Institute of Life Sciences and Green Development, Hebei University, Hebei, China. “As ...

New study in JNCCN supports chemotherapy option that reduces side effects for people with gastrointestinal cancers

New study in JNCCN supports chemotherapy option that reduces side effects for people with gastrointestinal cancers
2024-09-05
PLYMOUTH MEETING, PA [September 5, 2024] — New research just-published online by JNCCN—Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic gastrointestinal (GI) cancers, such as FOLFOX, FOLFIRI, or FOLFIRINOX, it is possible to administer 5-FU solely through continuous infusion, minus the bolus (quick-delivery via intravenous push) component, without negatively affecting patient outcomes. The study reviewed results from 11,765 patients across 280 cancer clinics who were diagnosed with ...

Study shows long term-effects of immigration on Chinese Americans’ cardiovascular health

2024-09-05
A new UCLA-led study found that cardiovascular disease risk among Chinese American immigrants increases with length of residence and varies by location in the U.S. The study, which leveraged data from the MESA (Multi-Ethnic Study of Atherosclerosis) cohort, sponsored by the National Heart, Lung, and Blood Institute (NHLBI), observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. The study found that participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived in Los Angeles. “This is the first long-term prospective study in nearly two decades to investigate the effects of ...

High blood pressure a concern for adolescents and young adults in U.S.

2024-09-05
Research Highlights: In the first study, nearly 23% of young adults (ages 18-39 years) included in the NHANES 2017-2020 datasets had high blood pressure (130/80 mm Hg or greater). In addition, they were more likely to self-report being uninsured, food insecure and low-income compared to older adults. The second study, which also used the 2017-2020 NHANES datasets, found that among 2,600 youths ages 8-19, 8.7% had elevated blood pressure and 5.4% had high blood pressure, as defined by age-sex-height percentiles in accordance with guidelines from the American Academy of Pediatrics. These two studies point to the need for policies and programs to support youth and young adults ...

Remote monitoring and pharmacist helped improve hard-to-control blood pressure

2024-09-05
Research Highlights: A new study finds that up to 74% of participants with resistant or difficult-to-control high blood pressure, including those with chronic kidney disease, were able to improve control of their blood pressure within 12 months after using a Bluetooth-enabled remote monitoring system coupled with pharmacist interactions. Two-thirds of patients had interacted with pharmacists who co-managed their blood pressure via telehealth, often making medication adjustments and addressing medication adherence, which was associated with ...

Popular home blood pressure monitoring cuff devices may not fit some US adults

2024-09-05
Research Highlights: An analysis of at-home blood-pressure monitors estimates that the arm cuffs for 10 of the most popular potentially do not fit up to 18 million adults in the U.S. and nearly 12% of Black adults. To ensure accurate blood pressure monitoring, the researchers suggest that manufacturers and retailers be aware of the disparities and improve access and selection of diverse blood pressure cuff sizes for consumers. Note: The studies featured in this news release are research abstracts. Abstracts ...

How fish guts might play a role in future skin care products

2024-09-05
There are some pretty strange ingredients in cosmetics and skin care products. One example is snail mucin — also known as snail slime — which is used for its moisturizing and antioxidant properties. But researchers reporting in ACS Omega might have found something even weirder to put on your face: molecules made by fish gut bacteria. In cultured cells, the compounds had skin-brightening and anti-wrinkle properties, making them potential ingredients for your future skin care routine. Though fish guts might seem like the absolute last place to look for cosmetic compounds, it’s not a completely far-fetched idea. Many important drugs have ...

Research update: Recreational tubing, swimming leaves an impact on streams

2024-09-05
How does your dip in a local watering hole affect the stream’s chemistry? Researchers who previously analyzed the impact of people swimming and tubing on a Colorado creek report updated observations in ACS ES&T Water. They find that these recreational activities over a busy Labor Day weekend have a short-term effect, increasing the levels of metals, human gut-associated microbes and substances from personal care products. Researchers James Ranville, Carsten Prasse, John Spear, Noor Hamden, Carmen Villarruel and colleagues studied how recreational ...

Asian Fund for Cancer Research announces winner of the 2024 BRACE Award Venture Competition

Asian Fund for Cancer Research announces winner of the 2024 BRACE Award Venture Competition
2024-09-05
Hong Kong (5 September 2024) – The Asian Fund for Cancer Research Limited (AFCR) is pleased to announce the winners of the 2024 BRACE Award Venture Competition: the First Prize goes to Concarlo Therapeutics, led by Founder and CEO Stacy Blain, Ph.D., and the Second Prize goes to Orphagen Pharmaceuticals, led by its Founder and CEO Scott Thacher, Ph.D. AFCR’s BRACE (Bridging Research from Academia to Cancer Entrepreneurship) Award Venture Competition is designed to support and accelerate oncology innovations on their path toward commercialization, aiming to improve outcomes for patients affected by cancer globally. ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] Cause, potential treatments ID'd for persistent COVID-19 lung problems